| ||
| MolMed expands Phase III trial of NGR-hTNF for the treatment of mesothelioma ... PharmaLive (press release) (subscription) In addition to Phase III trial in mesothelioma, currently ongoing randomised trials of NGR-hTNF include two Phase II trials, for non-small-cell lung cancer and for soft tissue sarcomas. Other Phase II trials of NGR-hTNF include completed trials for ... See all stories on this topic » |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment